An Exploratory Study of Iliac Artery Branch Stent for Internal Iliac Artery Reconstruction in Abdominal Aortic Aneurysm/Iliac Aneurysm Repair
Comparing the Efficacy and Safety of IBD Stent of Shenzhen Xianjian Company and IBE Stent of American Gore Company for Reconstruction of Internal Iliac Artery in Abdominal Aortic Aneurysm/Iliac Aneurysm Repair
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Guanhua Xue, M.D.
- Phone Number: 13585785270
- Email: guanhuaxue@yeah.net
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 200127
- Renji Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients with iliac aneurysms combined with or without abdominal aortic aneurysms and internal iliac arteries reconstructed with iliac branch stents;
- Male or female ≥18 years old, ≤85 years old;
- Life expectancy > 2 years;
- The patient signed the informed consent voluntarily and was able to comply with the treatment plan and complete the follow-up and examination as planned.
Exclusion Criteria:
- Fungal or ruptured aneurysm
- Known complications of thoracic aortic aneurysm require interventional treatment
- American Association of Anesthesiologists (ASA) Grade V
- Creatinine > 2.5mg/dL or dialysis patients
- NYHA Grade IV heart failure
- Intercalation, severe calcification, or anchoring area with thrombosis
- Severe curvature or narrowing of the iliac and/or femoral arteries, resulting in difficulty in stent delivery
- Conduct another device or drug study within 1 year of treatment
- Systemic infection
- Combined with connective tissue disease
- Known history of drug use
- Known allergies or allergies to equipment materials
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore company
Patients underwent endovascular treatment for reconstruction of internal iliac artery in abdominal aortic aneurysm/iliac aneurysm repair.
The lesion will be treated by IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore Company.
|
Patients underwent endovascular treatment for reconstruction of internal iliac artery in abdominal aortic aneurysm/iliac aneurysm repair.
The lesion will be treated by IBD stent of Shenzhen Xianjian Company and IBE stent of American Gore Company.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Primary patency
Time Frame: 12-month
|
CTA showed patency of the preserved internal iliac artery.
|
12-month
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
New hip lameness
Time Frame: 12-month
|
New hip lameness is defined as new hip claudication in the lateral body treated with an iliac artery branch stent.
|
12-month
|
|
Internal leakage
Time Frame: 12-month
|
Internal leakage is defined as any type of internal leakage that occurs during the follow-up period.
|
12-month
|
|
Aneurysmal enlargement
Time Frame: 12-month
|
Aneurysm enlargement is defined as having a larger aneurysm diameter during follow-up than before surgery.
|
12-month
|
|
Aneurysm rupture
Time Frame: 12-month
|
Ruptured aneurysms is defined as ruptured abdominal aortic aneurysms or iliac aneurysms that occurrs during follow-up.
|
12-month
|
|
Secondary patency
Time Frame: 12-month
|
Secondary patency is defined as maintaining patency in the target vessel after a repeat intervention to correct complete occlusion in the treated arterial segment.
|
12-month
|
|
Secondary endovascular repair surgery
Time Frame: 12-month
|
Secondary endovascular repair is defined as secondary surgical intervention that occurrs during follow-up due to adverse events such as internal leakage and distal limb ischemia.
|
12-month
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- The SIRI study
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.